Skip to main content

Our group uses proteomics in combination with other -omics technologies, such as metabolomics, lipidomics and microRNA profiling, to integrate biological information in disease-specific networks that drive pathopysiological changes. While studying molecular interactions has been a research focus for many years and has provided important insight into biology, the attention has now shifted towards a more integrative network biology approach.

Our Partners


British Heart Foundation

University of Oxford

University of Oxford

FFG logo


MUI, Medizinischen Universität Innsbruck logo

MUI, Medizinischen Universität Innsbruck

Logo for UKE Hamburg

UKE Hamburg

University Medicine Göttingen

University Medicine Göttingen

Logo for UKD Dusseldorf

UKD Dusseldorf

Logo for Mount Sinai

Mount Sinai

Logo for CARIM Maastricht

CARIM Maastricht

Group lead

Contact us

Manuel Mayr - Professor of Cardiovascular Proteomics

Follow us